{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:05:44Z","timestamp":1761660344078,"version":"build-2065373602"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s10067-025-07692-6","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:43:18Z","timestamp":1758631398000},"page":"4749-4758","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serological distribution of anti-endothelial cell antibodies and their association with laboratory indicators in autoimmune and immune-mediated diseases"],"prefix":"10.1007","volume":"44","author":[{"given":"Renren","family":"Ouyang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rujia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiji","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2337-0509","authenticated-orcid":false,"given":"Hongyan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"7692_CR1","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0065-2423(06)42008-4","volume":"42","author":"C Alessandri","year":"2006","unstructured":"Alessandri C, Bombardieri M, Valesini G (2006) Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv Clin Chem 42:297\u2013326","journal-title":"Adv Clin Chem"},{"issue":"15\u201316","key":"7692_CR2","first-page":"660","volume":"112","author":"S Praprotnik","year":"2000","unstructured":"Praprotnik S et al (2000) Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis. Wien Klin Wochenschr 112(15\u201316):660\u2013664","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"7692_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.autrev.2016.12.012","volume":"16","author":"P Legendre","year":"2017","unstructured":"Legendre P et al (2017) Anti-endothelial cell antibodies in vasculitis: a systematic review. Autoimmun Rev 16(2):146\u2013153","journal-title":"Autoimmun Rev"},{"issue":"1","key":"7692_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1517\/14712598.2011.540234","volume":"11","author":"R Karasawa","year":"2011","unstructured":"Karasawa R et al (2011) Anti-endothelial cell antibodies (AECA) in patients with systemic vasculitis: our research using proteomics. Expert Opin Biol Ther 11(1):77\u201387","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"7692_CR5","doi-asserted-by":"publisher","first-page":"725","DOI":"10.5114\/ada.2019.84230","volume":"37","author":"MM Michalska-Jakubus","year":"2020","unstructured":"Michalska-Jakubus MM et al (2020) Anti-endothelial cell antibodies are associated with apoptotic endothelial microparticles, endothelial sloughing and decrease in angiogenic progenitors in systemic sclerosis. Postepy Dermatol Alergol 37(5):725\u2013735","journal-title":"Postepy Dermatol Alergol"},{"issue":"2","key":"7692_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/ard.2008.102400","volume":"69","author":"C Mihai","year":"2010","unstructured":"Mihai C, Tervaert JW (2010) Anti-endothelial cell antibodies in systemic sclerosis. Ann Rheum Dis 69(2):319\u2013324","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"7692_CR7","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3899\/jrheum.091346","volume":"37","author":"N Del Papa","year":"2010","unstructured":"Del Papa N et al (2010) Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. J Rheumatol 37(10):2053\u20132063","journal-title":"J Rheumatol"},{"issue":"5","key":"7692_CR8","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00296-022-05104-5","volume":"42","author":"P Cieslik","year":"2022","unstructured":"Cieslik P et al (2022) The impact of anti-endothelial cell antibodies (AECAs) on the development of blood vessel damage in patients with systemic lupus erythematosus: the preliminary study. Rheumatol Int 42(5):791\u2013801","journal-title":"Rheumatol Int"},{"issue":"2","key":"7692_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000508","volume":"3","author":"H Tyden","year":"2017","unstructured":"Tyden H et al (2017) Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus. RMD Open 3(2):e000508","journal-title":"RMD Open"},{"key":"7692_CR10","doi-asserted-by":"publisher","first-page":"178721","DOI":"10.1155\/2014\/178721","volume":"2014","author":"A Mak","year":"2014","unstructured":"Mak A, Kow NY (2014) Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus. Biomed Res Int 2014:178721","journal-title":"Biomed Res Int"},{"issue":"2","key":"7692_CR11","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29(2):288\u2013291","journal-title":"J Rheumatol"},{"issue":"6","key":"7692_CR12","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"G Wells","year":"2009","unstructured":"Wells G et al (2009) Validation of the 28-joint disease activity score (DAS28) and European league against rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis 68(6):954\u2013960","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"7692_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1046\/j.1365-2249.2002.02000.x","volume":"130","author":"E Grunebaum","year":"2002","unstructured":"Grunebaum E et al (2002) The role of anti-endothelial cell antibodies in Kawasaki disease - in vitro and in vivo studies. Clin Exp Immunol 130(2):233\u2013240","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"7692_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001244","volume":"5","author":"V Duong","year":"2011","unstructured":"Duong V et al (2011) Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Negl Trop Dis 5(7):e1244","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"7692_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1590\/abd1806-4841.20198169","volume":"94","author":"DA Arica","year":"2019","unstructured":"Arica DA et al (2019) High levels of endothelial progenitor cells and circulating endothelial cells in patients with Behcet\u2019s disease and their relationship to disease activity. An Bras Dermatol 94(3):320\u2013326","journal-title":"An Bras Dermatol"},{"key":"7692_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/biom11010081","author":"J Maiuolo","year":"2021","unstructured":"Maiuolo J et al (2021) Endothelial dysfunction and extra-articular neurological manifestations in rheumatoid arthritis. Biomolecules. https:\/\/doi.org\/10.3390\/biom11010081","journal-title":"Biomolecules"},{"issue":"1","key":"7692_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002960000060","volume":"20","author":"J Song","year":"2000","unstructured":"Song J et al (2000) Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int 20(1):1\u20137","journal-title":"Rheumatol Int"},{"issue":"5","key":"7692_CR18","first-page":"497","volume":"6","author":"XD Liu","year":"2014","unstructured":"Liu XD et al (2014) Anti-endothelial cell antibodies in connective tissue diseases associated with pulmonary arterial hypertension. J Thorac Dis 6(5):497\u2013502","journal-title":"J Thorac Dis"},{"issue":"1","key":"7692_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1001-9294(10)60016-8","volume":"25","author":"MT Li","year":"2010","unstructured":"Li MT et al (2010) Prevalence of anti-endothelial cell antibodies in patients with pulmonary arterial hypertension associated with connective tissue diseases. Chin Med Sci J 25(1):27\u201331","journal-title":"Chin Med Sci J"},{"issue":"4","key":"7692_CR20","doi-asserted-by":"publisher","first-page":"R366","DOI":"10.1186\/ar1198","volume":"6","author":"F Conti","year":"2004","unstructured":"Conti F et al (2004) Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for anti-endothelial-cell antibodies. Arthritis Res Ther 6(4):R366\u2013R372","journal-title":"Arthritis Res Ther"},{"key":"7692_CR21","doi-asserted-by":"publisher","first-page":"811504","DOI":"10.3389\/fmed.2022.811504","volume":"9","author":"M Blasco","year":"2022","unstructured":"Blasco M et al (2022) Complement mediated endothelial damage in thrombotic microangiopathies. Front Med (Lausanne) 9:811504","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"7692_CR22","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/MCA.0b013e32833d5fae","volume":"21","author":"DG Katritsis","year":"2010","unstructured":"Katritsis DG et al (2010) Antiendothelial cell antibodies in patients with coronary artery ectasia. Coron Artery Dis 21(6):352\u2013356","journal-title":"Coron Artery Dis"},{"issue":"2","key":"7692_CR23","first-page":"e70057","volume":"6","author":"T Xia","year":"2025","unstructured":"Xia T et al (2025) Vascular endothelial cell injury: causes, molecular mechanisms, and treatments. Med Comm (2020) 6(2):e70057","journal-title":"Med Comm (2020)"},{"issue":"3","key":"7692_CR24","doi-asserted-by":"publisher","first-page":"586","DOI":"10.34067\/KID.0006432020","volume":"2","author":"AD Morris","year":"2021","unstructured":"Morris AD et al (2021) Biomarkers in ANCA-associated vasculitis: potential pitfalls and future prospects. Kidney 360 2(3):586\u2013597","journal-title":"Kidney 360"},{"key":"7692_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020805","author":"FK Alduraibi","year":"2024","unstructured":"Alduraibi FK, Tsokos GC (2024) Lupus nephritis biomarkers: a critical review. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25020805","journal-title":"Int J Mol Sci"},{"issue":"1","key":"7692_CR26","first-page":"50","volume":"40","author":"JC Tseng","year":"2007","unstructured":"Tseng JC et al (2007) Elevated serum anti-endothelial cell autoantibodies titer is associated with lupus nephritis in patients with systemic lupus erythematosus. J Microbiol Immunol Infect 40(1):50\u201355","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07692-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07692-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07692-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:00:54Z","timestamp":1761660054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07692-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["7692"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07692-6","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors contributed to the article and approved the submitted version.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}